US Stock MarketDetailed Quotes
BNR Burning Rock Biotech
- 7.150
- 0.0000.00%
Close May 31 16:00 ET
- 7.430
- +0.280+3.92%
Post 17:43 ET
73.35MMarket Cap-897P/E (TTM)
0.000High0.000Low413Volume7.370Open7.150Pre Close3.17KTurnover0.01%Turnover RatioLossP/E (Static)10.26MShares26.10052wk High0.74P/B39.87MFloat Cap5.72252wk Low--Dividend TTM5.58MShs Float397.500Historical High--Div YieldTTM0.00%Amplitude5.720Historical Low7.665Avg Price1Lot Size
Burning Rock Biotech Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -11.85%125.62M | -4.58%537.44M | -14.87%121.09M | -17.50%127.57M | 11.79%146.27M | 5.16%142.52M | 10.90%563.24M | -3.47%142.24M | 22.13%154.63M | 2.80%130.85M |
| Operating revenue | -11.85%125.62M | -4.58%537.44M | -14.87%121.09M | -17.50%127.57M | 11.79%146.27M | 5.16%142.52M | 10.90%563.24M | -3.47%142.24M | 22.13%154.63M | 2.80%130.85M |
| Cost of revenue | -8.72%39.93M | -4.91%174.21M | 4.88%42.97M | -9.54%41.65M | -4.97%45.85M | -8.76%43.74M | 27.47%183.2M | -2.36%40.97M | 31.46%46.04M | 30.22%48.24M |
| Gross profit | -13.24%85.69M | -4.42%363.23M | -22.86%78.11M | -20.88%85.92M | 21.57%100.42M | 12.78%98.77M | 4.36%380.04M | -3.91%101.26M | 18.56%108.59M | -8.45%82.6M |
| Operating expense | -26.36%211.52M | -24.10%1.03B | -23.30%244.44M | -22.87%264.74M | -32.15%236.15M | -18.04%287.23M | 17.16%1.36B | -10.85%318.71M | 30.69%343.24M | 19.09%348.06M |
| Selling and administrative expenses | -24.52%145.54M | -26.96%685.53M | -21.37%171.32M | -22.57%181.03M | -45.16%140.37M | -16.51%192.81M | 18.31%938.58M | -10.99%217.88M | 21.15%233.81M | 38.96%255.95M |
| -Selling and marketing expense | -27.66%46.86M | -33.10%247.71M | -41.55%49.79M | -30.98%62.31M | -32.94%70.84M | -27.39%64.77M | 22.17%370.29M | -17.48%85.17M | 17.72%90.28M | 55.21%105.63M |
| -General and administrative expense | -22.93%98.68M | -22.96%437.82M | -8.42%121.53M | -17.28%118.72M | -53.75%69.53M | -9.66%128.04M | 15.92%568.28M | -6.26%132.71M | 23.41%143.53M | 29.44%150.32M |
| Research and development costs | -30.11%65.99M | -17.74%347.02M | -27.48%73.12M | -23.51%83.7M | 3.98%95.78M | -20.99%94.42M | 14.68%421.87M | -10.55%100.83M | 57.12%109.43M | -14.77%92.11M |
| Operating profit | 33.23%-125.83M | 31.73%-669.32M | 23.51%-166.32M | 23.79%-178.82M | 48.87%-135.72M | 28.30%-188.46M | -23.00%-980.41M | 13.76%-217.44M | -37.18%-234.64M | -31.40%-265.46M |
| Net non-operating interest income expense | 28.44%4.04M | 89.85%17.96M | 95.17%5.54M | 99.60%4.02M | 97.85%5.26M | 61.15%3.14M | 392.35%9.46M | 202.88%2.84M | 240.61%2.01M | 2,189.66%2.66M |
| Non-operating interest income | 28.44%4.04M | 89.85%17.96M | 95.17%5.54M | 99.60%4.02M | 95.72%5.26M | 61.15%3.14M | 173.59%9.46M | 175.27%2.84M | 110.13%2.01M | 294.27%2.69M |
| Non-operating interest expense | ---- | --0 | ---- | ---- | --0 | ---- | ---- | --0 | ---- | -94.87%29K |
| Other net income (expense) | -12.84%421K | -96.24%64K | -227.05%-357K | -76.83%266K | -143.68%-328K | 200.84%483K | 359.69%1.7M | 125.48%281K | 187.00%1.15M | 691.34%751K |
| Gain on sale of security | 88.79%-13K | -127.11%-420K | -241.64%-517K | -68.36%423K | -133.65%-210K | 85.07%-116K | 281.38%1.55M | 149.93%365K | 251.84%1.34M | 211.43%624K |
| Other non- operating income (expenses) | -27.55%434K | 218.42%484K | 290.48%160K | 16.93%-157K | -192.91%-118K | 101.01%599K | -23.62%152K | 77.42%-84K | -1,045.00%-189K | -70.67%127K |
| Income before tax | 34.34%-121.37M | 32.80%-651.3M | 24.81%-161.14M | 24.60%-174.53M | 50.09%-130.8M | 29.29%-184.83M | -21.80%-969.25M | 15.05%-214.32M | -36.12%-231.48M | -29.70%-262.05M |
| Income tax | -57.35%180K | 20.30%2.39M | -43.66%1.07M | 450K | 429.76%445K | 422K | 120.80%1.99M | 265.16%1.9M | 0 | -94.83%84K |
| Net income | 34.39%-121.55M | 32.69%-653.69M | 24.98%-162.21M | 24.41%-174.98M | 49.93%-131.24M | 29.13%-185.25M | -21.91%-971.23M | 13.90%-216.23M | -35.79%-231.48M | -28.71%-262.14M |
| Net income continuous Operations | 34.39%-121.55M | 32.69%-653.69M | 24.98%-162.21M | 24.41%-174.98M | 49.93%-131.24M | 29.13%-185.25M | -21.91%-971.23M | 13.90%-216.23M | -35.79%-231.48M | -28.71%-262.14M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 34.39%-121.55M | 32.69%-653.69M | 24.98%-162.21M | 24.41%-174.98M | 49.93%-131.24M | 29.13%-185.25M | -21.91%-971.23M | 13.90%-216.23M | -35.79%-231.48M | -28.71%-262.14M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 34.39%-121.55M | 32.69%-653.69M | 24.98%-162.21M | 24.41%-174.98M | 49.93%-131.24M | 29.13%-185.25M | -21.91%-971.23M | 13.90%-216.23M | -35.79%-231.48M | -28.71%-262.14M |
| Basic earnings per share | 34.25%-11.9 | 31.76%-63.8 | 25.12%-15.8 | 23.32%-17.1 | 48.80%-12.8 | 27.60%-18.1 | -22.22%-93.5 | 12.08%-21.1 | -35.98%-22.3 | -27.55%-25 |
| Diluted earnings per share | 34.25%-11.9 | 31.76%-63.8 | 25.12%-15.8 | 23.32%-17.1 | 48.80%-12.8 | 27.60%-18.1 | -22.22%-93.5 | 12.08%-21.1 | -35.98%-22.3 | -27.55%-25 |
| Dividend per share | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg